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Abstract  
 
The propensity to blush is typical of many individuals with social anxiety disorder (SAD). 
SAD is also associated with significant disability or functional impairment.  The relationship 
between SAD, blushing and functional impairment is still not completely understood 
however. This study has focused on the association between the propensity to blush and 
reported level of functional impairment due to SAD. Data from thirty-eight (n=38) 
individuals with SAD, were collected via a larger study conducted at the MRC Anxiety and 
Stress Disorders Unit. Assessment tools include the Structured Clinical Interview for Axis I 
disorders – Patient Version (SCID -I/P), Social Phobia Inventory (SPIN) and the Blushing 
Propensity Scale. Demographic and clinical data were gathered and reported on. Spearman 
rank order correlations were used to determine relationships between variables, including 
blushing propensity, disability and symptom severity. Results were reported on, and then 
discussed using the social attention theory. Limitations and recommendations were proposed 
in the final and concluding chapter. This study, as part of a larger study at the MRC Research 
Unit on Anxiety and Stress Disorders, has been approved by the Research Ethics Committee 
of the Faculty of Health Sciences of the University of Stellenbosch.  
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Chapter 1: Introduction 
 
Social anxiety disorder (SAD) is not only a common disorder (Stein & Stein, 2008; Schneier, 
Blanco, Antia & Liebowitz, 2002; Hidalgo, Barnett and Davidson, 2001), but it has been 
ranked as the third most common psychiatric disorder (Brunello, den Boer, Judd, Kasper, 
Kelsey, Lader, Lecrubier, Lepine, Lydiard, Medlewicz, Montgomery, Racagni, Stein & 
Wittchen, 2000) with a lifetime prevalence of up to 16% (Hidalgo et al 2001).  Among all 
mental and physical conditions, SAD is ranked in the top ten chronic conditions (Stein & 
Stein, 2008).  
 
Social Phobia or SAD is an excessive fear of one or more social or performance situations, 
such as meeting new people or speaking in public. The individual with SAD fears that under 
the scrutiny of others, they will act in an embarrassing or humiliating way (Sadock & Sadock, 
2003). Symptoms of this disorder are often associated with excessive avoidance of social or 
possible scrutiny situations, including initiating a conversation, applying for a promotion at 
work or going on dates.  These symptoms consequently cause significant impairment or 
disruption in daily functioning1 (Schneier, Blanco, Antia & Liebowitz, 2002; Brunello et al., 
2000), such as lower levels of educational achievement and school dropout (den Boer, 1995; 
Stein & Stein, 2008; Brunello et al., 2000; Hidalgo et al., 2001). There is also evidence for 
reduced occupational functioning (den Boer, 1995; Stein & Stein, 2008; Brunello et al., 2000; 
                                  
1 Impairment is defined by the Oxford Dictionary of Psychology (2006) as “any diminution in quality or 
strength; more specifically, any diminution in the quality or strength of physical or psychological functioning in 
some specified domain”. The DSM-IV (APA, 2000) states the following, “…each of the mental disorders 
is…..associated with present distress (e.g., a painful symptom) or disability (i.e. impairment in one or more 
important areas of functioning) or with significantly increased risk of suffering death, pain, disability or 
important loss of freedom.” Therefore, the terms “disability” and functional impairment” will be used 
interchangeably in this study.  
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Hidalgo et al., 2001), lower income (Schneier, Blanco, Antia & Liebowitz, 2002) and even 
unemployment (Brunello et al., 2000). Most notably, SAD sufferers struggle with personal 
relationships, (den Boer, 1997; Brunello et al., 2000) including family and partner 
relationships (Kessler, Berglund, Demler, Jin, Merikangas & Walters, 2005; Hidalgo et al., 
2001), as the literature shows over half of individuals with SAD are single, divorced or 
separated (Brunello et al, 2000).  
 
In addition to feeling extreme discomfort in social or performance situations and/or attempts 
at avoiding these, blushing is another of the key symptoms of SAD (Domschke, Stevens, 
Beck, Baffa, Hohoff, Beckert & Gerlach, 2009; Stein & Bouwer, 1997). Indeed, in comparing 
controls to SAD patients, the latter were found to be more prone to blushing (Domschke et 
al., 2009).  Blushing can be defined as an involuntary or spontaneous reddening of the face, 
ears and neck (Domschke et al., 2009), caused by the dilation of small blood vessels which 
results in increased blood volumes to that particular area (Leary, Britt, Cutlip & Templeton, 
1992). It is often accompanied by a feeling of warmth (Leary & Meadows, 1991; Stein & 
Bouwer, 1997) and is said to be caused by perceived social scrutiny or evaluation (Leary et 
al., 1992; Stein & Bouwer, 1997). In individuals with SAD, blushing may increase the 
extreme self-consciousness and the belief that he/she is being scrutinized, and may thus lead 
to further avoidance, withdrawal and impairment. Although much is known about SAD and 
its impact on people’s lives today, there still is a paucity of data of the relationship between 
SAD, blushing and patients’ disability. 
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1.1. Rationale  
SAD only became an official disorder in the 1980s with the publication of the DSM-III 
(APA, 1980) and only a decade ago was still being termed “highly prevalent, [yet] neglected 
and trivialised for decades by society and science” (Hidalgo et al 2001) and more recently 
called a disorder “once largely neglected by the medical community, [coming] to the 
attention of the general medical community a decade ago, and…now garnering increased 
attention and recognition as a widespread, impairing, but treatable condition” (Brunello et al., 
1996; Kessler et al., 2005; Stein & Stein, 2008).  As noted previously, SAD is associated with 
significant disability in all, and blushing in some cases. The relationship between these 
variables remains incompletely understood however (Stein & Bouwer, 1997; Leary et al, 
1992; Leary & Meadows, 1991). 
 
1.2. Aims and Objectives  
This study intends to provide further information on blushing in patients with SAD, by 
investigating the relationship between blushing propensity and functional impairment.  
 
1.2.1. Objectives include: 
i) determining blushing propensity in this sample of SAD sufferers 
ii) investigating the association between blushing propensity and the level of reported 
functional impairment 
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1.3. Hypotheses  
1. SAD sufferers have a propensity to blushing. 
2. This propensity to blush is positively correlated with the functional impairment associated 
with SAD. 
 
1.4. Significance of study  
SAD is an important focus area in Psychiatry, due to its high prevalence, early age of onset, 
significant economic burden and associated functional impairment.  The last decade or so has 
seen a steady increase in research focused on the clinical and other important aspects 
(genetics, brain imaging) of SAD.  Until recently however, few studies have focused on 
blushing phenomenology in SAD specifically.  Also, although much is known about the 
functional impairment associated with SAD in general, the relationship between blushing, 
functional impairment in particular, and SAD severity has not received much empirical 
attention. This study will add a valuable contribution to the current literature by elucidating 
the relationship between these aspects in patients with SAD.  
 
1.5. Chapter Organisation 
Chapter 1 is intended as a brief overview and introduction to the current study. It provides an 
introduction to the topic and the two focus areas with SAD, namely disability and blushing. 
Next, the rationale this study is presented and specific aims, objectives and hypotheses about 
the current study are set out. Lastly, the significance of the current study is presented.  
 
Chapter 2 provides a review of the current literature consulted regarding SAD. Two specific 
relationships are discussed with regarded to this literature. First, literature linking SAD and 
the propensity to blush is reported on. Secondly, literature linking SAD and functional 
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impairment in the disorder is reported on. The aim of this review is to lead the reader to 
consider a third relationship, namely the connection between blushing and disability within 
SAD. Lastly, this chapter presents Halberstadt and Green’s (1993) theory of social attention 
and will use this to frame the results.  
 
Chapter 3 is a summary of the specific methodology employed with this study. The current 
study falls within a large study and therefore the design and a brief background of the larger 
study is presented. The specific research procedures, the analyses done and the ethical 
considerations are also discussed in this chapter.  
 
Chapter 4 provides a report on the results of the analyses of the quantitative data obtained 
from the larger study. Data is organised into demographic variables, clinical variables, 
reliability analyses, correlational analyses and mediation analyses. Data is also presented in 
table format and the chapter is concluded with a brief summary of results.  
 
Chapter 5 is the final chapter and aims to bring together the results and literature examined in 
an insightful discussion on the relationship between blushing and disability in SAD. The 
identified theory is used in an attempt to frame the results and add valuable information to the 
current understanding of SAD. Lastly, limitations of the study, as well as future directions for 
research, are presented.  
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Chapter 2: Literature Review 
 
2.1 Introduction 
This section will review the current understanding and conceptualisation of SAD in the 
literature, with a focus on two specific relationships. Firstly, this review will discuss the 
relationship between SAD and the propensity of individuals with SAD to blush. Secondly, 
the relationship between SAD and its associated functional impairment will be elucidated. 
This will provide the background to the present study aimed at addressing the possible 
relationship between blushing, functional impairment in particular, and SAD.  Lastly, this 
review will frame a conceptualisation of SAD and its associated features within Halberstadt 
and Green’s (1993) Social Attention Theory. 
 
This review will lead towards the next section (results & discussion) and this study’s current 
focus, namely a possible relationship between the propensity (of individuals with SAD) to 
blushing and the functional impairment associated with SAD. 
 
2.2. SAD and the propensity to blush 
SAD is primarily characterised by intense anxiety in social situations, which often manifests 
as a blush response (Stein & Bouwer, 1997). In addition to blushing, symptoms specific to 
SAD include sweating, stammering and twitching (Rapee & Heimberg, 1997), leading to 
much distress and impaired quality of life.  
 
Certain individuals blush more than others, and of those, many intensely dislike their 
blushing. Individuals who suffer from SAD also frequently experience blushing, and often 
perceive their blushing as highly embarrassing and anxiety-provoking, especially in social 
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settings (Stein & Bouwer, 1997). As expected, blushing is thought to be a negative 
occurrence, especially as it is associated with negatively valenced emotions (Crozier, 2006). 
Even though those without SAD also hold the belief that blushing is a negative occurrence, 
individuals with SAD have a particularly negative perception of blushing, reportedly 
experiencing it as descriptive of their lack of worth and shame (Crozier, 2006). This 
increased negative perception of self in individuals with SAD who blush may arguably only 
serve to increase the already present functional impairment associated with SAD. 
 
Of those that perceive blushing as a negative occurrence, some experience it as so aversive 
that they develop a phobia of blushing. Fear of blushing phobia is also an important concern 
in SAD, as individuals with SAD are vulnerable to developing this heightened awareness and 
a fear of blushing which may require specific treatment (Bögels, Alberts, & De Jong, 1996). 
Interestingly, an association has been found between a fear of blushing and the propensity to 
blushing (Mulkens, De Jong, & Bijgels, 1997).  
 
Leary and Meadows (1991) developed the blushing propensity scale, a self-report tool 
measuring individual differences in the tendency to blush and the degree to which people 
blush in everyday social settings. To date, studies on blushing propensity have used self-
report measures alone, implying subjective reporting rather than objectively observed 
propensity to blush (Mulkens, De Jong, & Bijgels, 1997). High self-reporting of blushing 
propensity may be understood in two ways. Firstly, it may be that individuals who report high 
blushing propensity do blush objectively more and may be vulnerable to developing blushing 
phobia. However, it may also be understood from a cognitive framework. Such a formulation 
would imply that those who report a high blushing propensity believe that their blushing is 
more intense, occurs more frequently and is more visible than in others, thereby experiencing 
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themselves as different and abnormal according to social standards. These types of beliefs or 
perceptions of the self as socially abnormal are typical of individuals with SAD (Voncken & 
Bögels, 2008). This may further increase the negative perception of blushing and create even 
more anxiety or distress for such individuals (Mulkens, De Jong, & Bijgels, 1997).  
 
Blushing propensity appears to be highly correlated with fear or worry regarding how one is 
perceived or evaluated by other (Leary & Meadows, 1991). Those most concerned with how 
others’ regard them are also those individuals most fearful of negative evaluation, most easily 
embarrassed and most often socially anxious (Edelmann. 1987; Leary, 1983c; Schlenker & 
Leary, 1982 in Leary & Meadows, 1991). Individuals with SAD are characterised by their 
social anxiety and fear of negative evaluation. Blushing has also been called the ‘’hallmark of 
embarrassment and a prominent symptom of social phobia’’ (Gerlach, Wilhelm & Roth, 
2003). Therefore, there is a strong case for a link between SAD and the propensity to blush. 
However, in caution, one must note that not all those who blush fulfil the diagnostic criteria 
for SAD.  
 
In the last two decades, blushing has increasingly been studied and has been linked with SAD 
(Domschke et al., 2009; Stein & Bouwer, 1997). Further links have also been found between 
blushing and fear of negative evaluation, embarrassability, low self esteem, social avoidance 
and distress and heightened public self-consciousness or self-awareness (Leary & Meadows, 
1991; Leary et al., 1992). Blushing has also been linked with awkwardness and shyness 
(Leary & Meadows, 1991), as well as acute sensitivity and shame regarding inadequacies in 
social situations (Crozier, 2001) – all of these associated features are also characteristic of 
SAD (APA, 2000).  Interestingly, blushing also tends to occur in social situations and not 
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when these individuals are alone (Leary & Meadows, 1991) – a finding that again suggest a 
connection, or association between blushing and SAD. 
 
Due to the early age of onset, high prevalence rates, economic burden and associated 
functional impairment or disability, SAD remains an important concern on many levels – 
societal but also personal. In terms of the latter, blushing, with its known links to SAD 
(Domschke et al., 2009; Stein & Bouwer, 1997), coupled with the perception that it is a 
negative occurrence (Crozier, 2006), may heighten the level of disability in individuals with 
SAD. Thus, investigating the relationship between the propensity to blush in patients with 
SAD and disability and would increase our understanding of this condition.   
 
2.3. SAD and functional impairment 
SAD is characteristically associated with functional impairment, noted by the requirement in 
the DSM-IV-TR (APA 2000) that there be significant functional impairment or distress in 
order for the diagnosis to be made. In this section, the literature on functional impairment in 
individuals with SAD will be reviewed.  
 
In the present study, a self-report measure, the Sheehan Disability Scale, was used to assess 
the level of functional impairment. Despite the known limitations of self-reporting, it is 
important to look at the perceived level of functioning that an individual with SAD reports. 
Subjective well-being is a vital area of investigation in any condition, including SAD, as it is 
associated with functioning impairment in many domains such as education, occupation and 
in social areas (Safren et al, 1996/1997). A high level of functional impairment is likely to 
affect subjective feelings of well-being in individuals with SAD, with the likely outcome that 
self-appraisals are more negative. The level of perceived functional impairment is important 
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given its role in treatment compliance and response, as patients may perceive treatment 
outcomes based of subjective feelings of well-being, rather than symptom reduction (Safren, 
Heimberg, Brown & Holle, 1996/1997). However, current treatment approaches prioritise 
symptom reduction with little regard for reported level of functional impairment (Safren et al, 
1996/1997). 
 
Overall, patients with SAD experience impairment in SAD at school, at work and socially, 
Lader (1998) found that at least moderate impairment was experienced by all individuals with 
SAD at one point during the disorder. Wittchen and Beloch (1996) suggested that SAD 
symptom severity was found to generally peak in early adulthood, an important time when 
life decisions regarding education, career/occupation, friendships and partners (social) are 
made. Decisions made during this important stage of life may therefore be based on fear and 
anxiety, disabling the individual’s ability to make the best choices based on their 
circumstances. Impaired decision making ability may lead to negative consequences later on, 
where the individual with SAD may experience lower quality of life and perhaps miss out on 
opportunities those without SAD may experience due to better decision making during early 
adulthood. The implication therefore is that subsequently associated functional impairment is 
higher, due to the impact of symptom severity peaking in early adulthood. This also has 
further implications, as poor choices may lead to negative consequences, lower quality of life 
and missed opportunities, therefore also increasing functional impairment. It may be that this 
has an impact of functional impairment across the lifespan of an individual with SAD.  
 
Social impairment is most commonly noted in SAD. Lader (1998) reported that social 
impairment is a predictable feature of SAD, particularly because of the characteristic 
devaluation of their own abilities and performance in social settings. Most individuals 
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experience social interactions as positive events, an experience that is reinforced over time. 
However, in SAD, everyday social interactions are mostly experienced as aversive, which in 
turn is reinforced. This often leads to increased avoidance, whereby level of impairment may 
be subsequently increased (Safren et al, 1996/1997). Social impairment includes arenas such 
as dating, marriage and recreation (Lader, 1998), although individuals with SAD seem to 
report less impairment in family settings. Wittchen and Beloch (1996) also found that 
individuals with SAD had associated impairment in relationships, as there were less likely to 
be married and of those married, high rates of divorce existed. Interestingly, a study by 
Safren et al (1996/1997), marital status was found to be significantly related to quality of life 
(i.e. decreased functional impairment). The authors hypothesized that a spouse may be a 
source of support in social interactions, similar to a ‘’safe person’’ for an individual suffering 
from agoraphobia.  
 
Educational impairment is often present, with difficulties such as truancy, lying, stealing and 
fighting during school years associated with individuals with SAD (Lader, 1998). Wittchen 
and Beloch (1996) also report high levels of school drop-out in individuals with SAD. 
Wittchen and Beloch (1996) found occupational impairment in individuals with SAD to be 
due to decreased work productivity and high rates of absenteeism. Individuals with SAD also 
commonly experience higher rates of unemployment (Wittchen & Beloch, 1996) and 
financial dependence (Safren et al, 1996/1997). Interestingly, of the economic burden of 
anxiety disorders, Wittchen and Beloch (1996) report that these costs were actually due to 
decreased or lack of productivity, rather than treatment costs.  
 
Individuals with SAD not only experience functional impairment in educational, occupation 
and social arenas, but also experience impairment on a cognitive level. Anxiety disorders, 
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such as SAD, are thought to be maintained by specific cognitive biases. In SAD, distortions 
are specific to social settings and are thought not to occur in non-social settings. Interestingly 
though, a study by Voncken, Bögels & Peeters (2007) reports that similar cognitive biases 
seem to manifest in depression, a disorder often comorbid with SAD. These biases include 
self-blaming, negative self-perception, negative expectations of others’ evaluations and self-
criticism. However, these cognitive biases are not specific to social settings in depressive 
patients.  Psychiatric comorbidity is typical of SAD. Lader (1998) reports that high levels of 
functional impairment tended to result in increased risk of comorbidity, often alcoholism or 
depression. Literature also shows increased rates of suicidal ideation (Safren et al, 
1996/1997), although not significantly higher rates of attempted suicide in comparison to 
controls.  Wittchen and Beloch (1996) report that of individuals with SAD, only one third 
received treatment. Treatment received consisted of predominantly pharmacological 
interventions, with psychologists being consulted by only 13.8% of those individuals who 
sought treatment. Despite the impairment in functioning, individuals with SAD were shown 
to respond well to cognitive-behavioural treatment (Safren et al, 1996/1997), which did lead 
to increased positive reports of well-being. 
 
Individuals with SAD often worry about how they are perceived in social settings, for 
example, that they would appear nervous or behave in an inappropriate or awkward way. 
Individuals with SAD also struggle with distorted perceptions of how others evaluate them in 
social settings. Voncken and Bögels (2008) report on a study that found that and 
incongruence between how individuals with SAD perceive themselves and their beliefs about 
what others expect of them is part of the core of SAD. This implies that individuals with SAD 
believe that they are unable to meet others’ expectations of them due to their distorted 
perception of how others are appraising them.  In a study by Voncken and Bögels (2008), 
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they attempted to shed light on whether actual performance deficits existed in SAD, or 
whether SAD was due to cognitive distortions of social performance. Research has shown 
that SAD suffers do perceive their social performance in a distorted way (Voncken & Bögels, 
2008). Coupled with these findings, however, is research showing that individuals with SAD 
do in fact perform more poorly in social settings than individuals without SAD (Voncken & 
Bögels, 2008).   
 
Interestingly, Voncken and Bögels (2008) suggested that individuals with SAD may display 
actual performance deficits in terms of their social skills, for example during a conversation, 
due to the complex interpersonal behaviours required.  These are the behaviours that 
individuals with SAD often struggle with (such as listening, responding, showing interest). 
Interpersonal deficits may result from poorer social knowledge due to avoidance and 
consequent less social experience. Individuals with SAD in general seem to have difficulty 
interacting with others and show impairment in terms of the social skills required for 
developing friendships, often leading to lack of close relationships and consequent social 
exposure, overall (Voncken, Bögels & Peeters, 2007). 
 
2.4 Theoretical framework 
The next section conceptualises SAD and its associated features within the Social Attention 
Theory of Halberstadt and Green (1993). 
 
2.4.1 Social Attention Theory 
Halberstadt and Green (1993) propose that in order for blushing to occur, some form of 
attention and affective state must be present prior to the blush response. Therefore, social 
attention theory highlights specific elements in social situations that elicit blushing, namely: 
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attention, often undesired, that one receives from others in a social situation (Halberstadt & 
Green, 1993), the resulting perceived focus on the individual, their behaviour, performance or 
identity (Leary et al., 1992) and lastly, the affective state the individual then experiences 
(Halberstadt & Green, 1993). This theory hypothesises that individuals who experience more 
social anxiety are more prone to blushing (Halberstadt & Green, 1993).  
 
Evidence for social attention theory was found in a study (Halberstadt and Green, 1993), 
where blushing was found to correlate highly with embarrassability and interaction 
anxiousness. This is consistent with previous research (Leary et al, 1992; Leary & Meadows, 
1991). Furthermore, Leary et al (1992) speculated that the finding that blushing only occurs 
in the presence of others, and is almost always accompanied by gaze aversion, supports the 
undesired social attention hypothesis. Gaze aversion is thought to be a way of ‘disengaging’ 
and providing the individual with some concealment. Halberstadt and Green (1993) continue 
on to say that ‘the present relationship between blushing and concern about social attention 
was so large in magnitude’, with the implication that blushing and SAD are clearly linked.  
 
Social attention theory posits four elicitors of blushing. Firstly, blushing is elicited by threats 
to public identity. This is explained via the human need to maintain positive social standing; 
i.e. any perceived threats of negative evaluation are then said to cause a blush response 
(Leary et al, 1992). Secondly, praise or positive attention may also elicit blushing due to the 
realisation that one is actually being evaluated or a fear that the praise if unwarranted (Stein 
& Bouwer, 1997). Thirdly, scrutiny may cause blushing. This is thought to be due to simply 
being paid attention without any preceding negative event (Leary & Meadows, 1991). Lastly, 
blushing is also elicited by simply telling someone that they are blushing (Leary et al, 1992). 
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a. Threats to public identity 
Human beings are said to have an inherent desire for social interaction (Leary & Meadows, 
1991) and a need to maintain positive social standing. Therefore it is thought that much 
attention is directed towards how one is being evaluated or perceived (Leary et al, 1992), and 
negative evaluation is thus cause for concern to the individual (Stein & Bouwer, 1997). Any 
perceived ‘threats’ of negative evaluation are then said to cause a blush response to the felt 
anxiety (Leary & Meadows, 1991). Blushing indicates to others that the individual believes 
that he/she has behaved in an inappropriate, immoral incompetent or shameful way and has 
lost poise, which is thought to cause embarrassment. The embarrassing event, and resulting 
perceived threat to social identity, elicits blushing in a subconscious attempt to reduce the 
expected negative evaluation (Leary et al, 1992).  In SAD, monitoring one’s social standing 
or public identity is imperative. However, this process is distorted due to an individual with 
SAD’s negative bias (Rapee & Heimberg, 1997), and it can therefore be speculated that 
individuals with SAD are more prone to blushing in circumstances where their social 
standing or public identity is perceived to be threatened.  
 
b. Praise and other forms of positive attention 
Blushing may occur when one is praised, complimented, honoured or even when being sung 
‘happy birthday’ (Leary & Meadows, 1991). Various reasons have been offered for why 
positive attention cause blushing. These include a realization that one is actually being 
noticed, and perhaps evaluated, feeling self-conscious due to being elevated in status, fear of 
seeming arrogant or immodest, fear of responding ungraciously or without appreciation or 
even that the praise is unwarranted (Stein & Bouwer, 1997). Nevertheless, although blushing 
then occurs in a “positive” environment, the perception of the individual with SAD is still 
negative, i.e. one of being scrutinized or being “put on the spot”.  
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c. Scrutiny 
Indeed, simply being paid attention, without any preceding negative event, may cause 
blushing. This attention may cause anxiety to patients with SAD due to their concern about 
how they are being evaluated and fears about being found inadequate (Stein & Bouwer, 
1997). Other explanations may be discomfort with authority figures (feeling evaluated by the 
“boss” or superiors) or audiences (Leary & Meadows, 1991). Staring from others may also 
cause blushing, as it is often understood to be threatening or scrutinising, causing the 
individual to experience negative affect and desire escape (Leary et al, 1992).  
 
A portion of the population (non-SAD as well) blush simply when exposed to routine 
experiences. These people may be very sensitive and chronically fear evaluation or rejection, 
to the point where they avoid social situations (Leary & Meadows, 1991). Compared to 
patients with other mental disorders and healthy controls, SAD patients typically report these 
cognitions and emotions, and reports fearing negative evaluation the most of all (Rapee & 
Heimberg, 1997).  
 
d. Accusations of blushing 
Blushing is also elicited by simply telling someone that they are blushing. This may be 
because the individual with SAD then realizes that he/she has been noticed, and subsequently 
experiences the fear of scrutiny or negative evaluation, and an inability to “conceal” their 
perceived inadequacies.  This may feed into their high embarrassability (see above sections) 
and may lead to actual blushing or increased blushing.  This is consistent with the theory that 
when blushing is pointed out, perceived undesired social attention – and thus anxiety or even 
social avoidance behaviours - increases (Leary et al, 1992).  
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2.5 Conclusion 
In summary, this section focused on the current conceptualisation of SAD in the literature.  
Firstly, the characteristics of SAD, a disorder characterised by intense anxiety in social 
situations, was discussed.  Blushing was highlighted as one of the many distressing physical 
manifestations of this condition.  The positive correlation between SAD severity and blushing 
was noted.  The significant link between SAD and blushing was explained using the Social 
Attention Theory (Halberstadt and Green, 1993) and supporting studies done over the last 2 
decades.   
 
Secondly, the functional impairment associated with SAD (and blushing) was reviewed.  The 
extreme functional impairment experienced at school, at work and socially - often associated 
with poor self-esteem, excessive avoidance and distress, and increased psychiatric 
comorbidity, in individuals with social anxiety – were highlighted.  
 
The present study will attempt to further elucidate the associations between blushing, 
functional impairment in particular, and illness severity, in a sample of patients with a 
primary diagnosis of SAD.   
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Chapter 3: Methodology 
 
This study is quantitative in nature, with a focus on examining a possible association between 
blushing propensity and functional impairment in patients with SAD. Study results are 
intended to be the beginnings of exploration into the relationship between SAD, 
blushing/blushing propensity and functional impairment.  
 
3.1 Research Design  
This study made use of secondary data from a larger study run by the MRC Unit on Anxiety 
& Stress disorders at Stellenbosch University. The larger study is entitled “Genetics of 
Anxiety Disorders” and focuses on the clinical characteristics and genetic underpinnings of 
the obsessive-compulsive spectrum and anxiety disorders. This study includes the following 
disorders: obsessive-compulsive disorder (OCD), Tourette’s disorder and trichotillomania 
(i.e. some obsessive-compulsive spectrum disorders), as well as panic disorder with/out 
agoraphobia, SAD and posttraumatic stress disorder.  
 
The larger study primarily aims to determine whether anxiety disorders are familial, and to 
examine heritability by identifying specific genes involved in the development of each of the 
abovementioned disorders. It also aims to shed light on specific neurobiological mechanisms 
that play a role in the aetiology of these disorders, in order to inform prevention and 
treatment approaches. On a secondary level, this larger genetics study is also investigating the 
contribution of specific demographic and clinical variables to the heterogeneity of these 
disorders. Investigated variables include age of onset of the main or primary disorder, 
treatment response (to both pharmacotherapy and cognitive-behavioural therapy), psychiatric 
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comorbidity, personality features, medical conditions and family psychiatric history. 
Furthermore, the larger study intends to study the associations between etiological factors 
(clinical and genetic), phenomenology and outcome of these disorders.  
 
Since initiation of the project, numerous publications have emerged on clinical and genetic 
correlates of the above-mentioned anxiety and OCD spectrum disorders. Specifically with 
regard to SAD, two important articles have been published from this study in recent years, 
one regarding genetic and personality traits in patients with SAD (Lochner, Hemmings, 
Seedat, Kinnear, Schoeman, Annerbrink, Olson, Eriksson, Moolman-Smook, Allgulander & 
Stein, 2007) and another on a comparison on quality of life in obsessive-compulsive disorder 
(OCD), panic disorder and SAD (Lochner, Mogotsi, du Toit, Kaminer, Niehaus & Stein, 
2003).  Findings from the first collaborative paper, between researchers from the MRC Unit 
on Anxiety and Stress Disorders in South Africa and the Karolinska Institute in Sweden, 
suggested increased harm avoidance and decreased novelty seeking and self-directedness in 
SAD patients compared to controls.  Study findings also suggested a possible role for the 5-
HT2A T102C polymorphism in the development of SAD.  They concluded that to date genetic 
findings in SAD have been inconsistent but that serotonergic variants, and their associations 
with temperament traits (e.g. reward dependence) deserve further exploration, in the hope 
that endophenotypes relevant to SAD can ultimately be delineated.  The latter article, another 
study done as part of the collaborative project between South Africa and Sweden focusing on 
genetic and environmental factors contributing to anxiety disorders, focused on rates of 
childhood trauma in SAD and panic disorder patients.  Findings suggested that the SA 
patients showed higher levels of childhood trauma than their Swedish counterparts.  When 
data from both countries were combined, SAD patients reported higher rates of childhood 
emotional abuse compared to those with PD.  Interestingly, emotional abuse in childhood was 
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found to play a predictive role in SAD/PD in adulthood in the Swedish and the combined 
samples, and the same trend was found in the SA sample.  Both these papers contributed to 
the relative paucity of literature on the etiology of SAD (and PD).   
 
The current study has drawn data from the above-mentioned larger genetics study. More 
specifically, clinical data from SAD patients (irrespective of type, i.e. both generalized and 
specific SAD)) were extracted for use in the proposed analyses.  Data pertaining to SAD 
severity, functional impairment due to SAD and blushing propensity in SAD were 
investigated. This data has allowed the researcher to investigate SAD separately, as 
contrasted with the primary aim of the larger genetics study, which focused on the clinical 
variables and neurobiological mechanisms involved in the aetiology of a whole group of 
anxiety and OCD spectrum disorders. The current study is motivated by the paucity of 
knowledge regarding the seemingly intricate relationship between blushing, illness severity 
and functional impairment in individuals with SAD.  
 
3.2 Participants  
Adult patients (older than 18 years) with a primary diagnosis of SAD (both the generalised 
and specific type), were included in this study (n=38). Demographic data will be presented in 
the following chapter regarding results.  
 
3.3 Procedures 
3.3.1   Participant selection: 
Participants were recruited countrywide by advertisements in the media and recruitment calls 
to psychiatrists and psychologists, primary care practitioners, and advocacy groups like the 
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South African Depression and Anxiety Group (SADAG).  Advertisements requested potential 
participants to contact study personnel if they had a primary diagnosis of SAD or suspected 
that they may be suffering from SAD. A confidential telephonic screening interview was then 
administered by the incumbent and previous research assistants to Professor Lochner to 
determine whether an individual could be included in the larger study based on a set of 
specific inclusion and exclusion criteria. These were as follows: 
 
a) Criteria for inclusion: 
• participants younger than 18 years were included only if they gave assent and their 
parents or caregivers gave written consent for their participation 
• participants with a primary DSM-IV diagnosis of SAD (generalised or specific type) 
• participants should sign the informed consent form 
• participants voluntarily comply with study procedures 
 
b) Criteria requiring exclusion from the study: 
• presence of another primary Axis I disorder (assessed with SCID-I/P) 
• presence of psychosis 
• if individuals did not sufficiently understand the study aims and procedures 
• if individuals did not sign the informed consent form 
 
3.3.2.   Interview:  
If individuals were included in the study after the above-mentioned initial selection 
procedure, they were invited to participate in the study. Participation involved a once-off 
assessment at the MRC Unit on Anxiety & Stress Disorders, or other temporary offices in 
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Gauteng, Bloemfontein and Kwazulu-Natal rented for these purposes. An experienced 
clinical psychologist or other clinician with relevant expertise (employed by the MRC Unit 
on Anxiety & Stress Disorders) administered a once-off semi structured interview, lasting 
approximately 3-5 hours.  Data collected included demographic information such as gender, 
age, ethnicity, highest educational level and current employment status. Further clinical 
information collected were age of onset (of their SAD), psychiatric comorbidity, family 
psychiatric history, medical history and treatment history were also gathered. Rating scales, 
including those specific to the current study, were administered both during the interview and 
in self-report format and are described in 3.3.3 below. Self-report questionnaires are given to 
the participant after the interview and are completed at home. Questionnaires are returned to 
the MRC Unit on Anxiety & Stress Disorders once completed.  
 
3.3.3.    Rating Scales  
For the purposes of this current study, data from specific rating scales were extracted from 
the original data set of the larger genetics study. There are data from four scales that were 
included in the current data set. Data pertaining to the study included diagnostic information 
(Axis I and II), the severity of the primary disorder (SAD in particular), the degree of 
blushing propensity and the degree of functional impairment experienced by the individual, 
due to SAD specifically.  
 
The Structured Clinical Interview for Axis I – Patient Version (SCID-I/P) provided 
information regarding the participants’ primary diagnosis (in this study’s sample – SAD) and 
their specific symptoms. The Social Phobia Inventory (SPIN) provided information regarding 
the severity of the disorder (SAD). The Blushing Propensity Scale (BPS) provided 
information on each SAD sufferer’s (in this sample) propensity to blush. Lastly, the Sheehan 
 
 
 
 
23 
 
Disability Scale (SDS) provided information regarding functional impairment associated with 
the participant’s SAD.  These questionnaires will be discussed in more detail below. 
 
a) SCID-I/P 
The SCID-I/P was used to assess participants’ primary DSM-IV diagnosis. Selected parts of 
the Structured Clinical Interview for Axis II Disorders – Patient Version (SCID-II/P) were 
used to assess for psychiatric comorbidity (First, Gibbon, Spitzer, Williams & Benjamin, 
1994). Both of these diagnostic tools (SCID-I/P and SCIP-II/P) have a high degree of validity 
(First et al, 1994; First, Spitzer, Gibbon & Williams, 1995) and are used frequently in the 
research field of psychiatry.  
 
b) SPIN 
The severity of the participants’ SAD symptomatology was assessed using the Social Phobia 
Inventory (SPIN) (reference here). The SPIN is a self-report measure with 17 items, requiring 
the individual to rate each item on a scale from 0 to 4 (4 being the highest level of distress), 
with a maximum score of 68 (minimum 0). Questions cover three dimensions, which include 
fear, avoidance and physiological discomfort. This scale was originally developed by Connor, 
Davidson, Churchill, Sherwood, Weisler and Foa (2000). The reliability was found to be 
good, with strong internal consistency ranging between 0.87 - 0.94.  Good construct validity 
was shown, with a diagnostic accuracy of 79%, as well as good convergent (P < 0.0001) and 
divergent (P < 0.03) validity (reference here).   
 
c) BPS 
A second self-report measure, the BPS, was used to assess blushing propensity and provided 
information vital to the current study. This self-rating questionnaire was developed by Leary 
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and Meadows (1991) and sets out fourteen different social situations in which the participant 
is asked to rate their propensity to blush (measured on a five point Likert scale: 0 – never, 5 – 
always). Leary and Meadows (1991) developed this scale as there was no existing scale 
measuring blushing propensity at the time. They aimed to develop a scale that could assist in 
investigating predictors of blushing propensity. They also intended for the scale to be able to 
provide information about the blushing experience. These scale developers suggested that 
blushing propensity is associated with social relationships and the importance placed on 
them; therefore, the BPS seem particularly appropriate for use in a sample of SAD patients. 
 
Regarding psychometric properties, high internal consistency was found for all 14 items and 
Cronbach’s alpha coefficient was 0.86. Strong evidence was also found for construct validity 
(Leary & Meadows, 1991).  
 
d) SDS 
The third self-report measure, the SDS, was used to assess the level of functional impairment 
due to SAD in individuals presenting with a primary diagnosis of SAD. Three levels of 
current functional impairment or disability are assessed, namely work, social and family life, 
via a self-rating scale from 0 to 10. A study by Hambrick, Turk, Heimberg, Scheier & 
Liebowitz (2004) reports reliability of the measure to be reasonable (Cronbach’s alpha = 
0.55). Hambrick et al (2004) found good validity as evidenced by strong relationships 
between the SDS and two other well-known disability measures, i.e. Liebowitz Self-Rated 
Disability Scale and the clinician-rated Disability Profile.  
 
 
 
 
 
25 
 
3.4. Statistical Analysis  
Descriptive statistical analyses were carried out in order to provide information on 
demographic (i.e. age, gender) and clinical (including age of onset of SAD, SAD severity, 
blushing propensity, functional impairment) variables. Spearman correlations were used to 
determine the existence (and direction) of significant associations between SAD severity and 
functional impairment in SAD, blushing propensity and SAD severity, and blushing 
propensity and functional impairment. Regression analyses were then carried out to 
determine the contribution of blushing propensity (independent variable) to functional 
impairment associated with SAD (the dependent variable). A Sobel test was performed to 
investigate the potential mediating role of SAD severity.  
 
Cronbach’s alpha, a coefficient of reliability, was also calculated for the items of each of the 
3 self-report rating scales.  Cronbach's alpha will generally increase as the intercorrelations 
among scale items increase. Because intercorrelations among scale items are maximized 
when all items measure the same construct, Cronbach's alpha is widely believed to indirectly 
indicate the degree to which a set of items measures a single unidimensional latent construct  
(such as functional impairment or propensity to blush) (Cronbach, 1951). Adequate Cronbach 
alphas for questionnaire items would thus be important in drawing conclusions from data 
obtained with these questionnaires,  
 
p-values smaller than 0.05 were considered to be significant with p-values between 0.05 and 
0.085 considered as trends towards significance. 
 
The statistical packages SPSS and Statistica were used to perform the analyses. 
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3.5. Ethical Considerations 
All potential participants were presented with a complete written description of the study.  In 
addition, study procedures were also verbally explained to each participant by the 
interviewer, with the opportunity to ask questions. Once everything was clear to participants, 
they were required to sign the informed consent from. Participants were informed of the 
confidentiality of data, notwithstanding any publications, and that all identifying information 
would be anonymised. Only relevant personnel, including the incumbent, are permitted to 
access this data. Participants were also informed that they would not be disadvantaged in any 
way should they withdraw from the study. If it was requested, participants were reimbursed 
for travel expenses. Treatment options were also discussed with participants and referrals 
were made if necessary. The Research Ethics Committee of the Faculty of Health Sciences of 
the University of Stellenbosch has approved the study protocol and patient information on 
consent forms on an annual basis. The guidelines of the International Conference on 
Harmonisation Good Clinical Practice Guidelines (ICH/GCP, 1996), The Declaration of 
Helsinki (Edinburgh, 2000) and the Medical Research Council of South Africa’s guidelines 
(2002) on the ethical conduct of research in humans have all been adhered to in this study.  
 
3.6. Conclusion 
In conclusion, this chapter has demonstrated the research methodology of this study. The 
following chapter will provide a report of the results generated in this study.  
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Chapter 4: Results 
 
4.1 Introduction 
This section will present the results of the data analyses in the following order. First, 
demographic variables and clinical variables of the sample will be reported. Secondly, 
reliability analyses performed will be reported on for all three rating scales (BPS, SDS, and 
SPIN) used in this study. Thirdly, all correlational analyses performed between all three 
variables (blushing propensity, disability in SAD, SAD severity) in this study will be reported 
on. Lastly, the mediation analyses (done by means of a Sobel test) will be reported on. 
 
4.2 Demographic Variables 
This sample consisted of 38 adult participants, all with a primary DSM-IV diagnosis of SAD. 
Demographically, the sample was made up of 24 males and 14 females. The mean age of 
onset of SAD was 15 (SD: 9), ranging from age 3 to 41. According to population groups, 19 
participants were white South African Afrikaans speaking, 12 were white South African 
English speaking, 5 were coloured South African and 2 were from other population groups. 
Further demographics of this sample include the mean age at the time of the interview, which 
was 36 (SD: 12), ranging from age 18 to 62. Educationally, 14 participants’ highest 
qualification was grade 11-12, for another 13 it was university, with another 8 having been at 
college (3 other). Occupationally, 10 reported professional employment, 8 reported being 
employed in sales, admin or clerical position and 6 reported being a student (10 other). 10.5% 
of the sample (4 participants) was unemployed at the time of the interview.  
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4.3 Clinical Variables 
Figure 1 (see below) provides a summary of the clinical variables in the current study. 
Results for all three ratings scales are reported in the table. The first scale, the Social Phobia 
Inventory (SPIN), has a maximum score of 68 and was used to assess symptom severity in 
the sample. The second scale, the Blushing Propensity Scale (BPS), has a maximum score 
of 70 and was used to assess the propensity to blush in this sample of SAD sufferers. The 
third scale, the Sheehan Disability Scale (SDS), is an instrument that measures functional 
impairment. It provides four scores – a total (maximum score is 30) and three subscale totals 
(maximum score on each is 10). Each subscale assesses a different area of impairment – 
namely ‘’work’’, ‘’social life’’ and ‘’family life/home responsibilities’’. 
 
Figure 1: Clinical Variables 
 
SPIN 
Total 
BPS 
Total 
SDS 
Work 
SDS 
Social 
SDS 
Family 
SDS 
Total 
Mean 43.8947 49.1316 4.4474 7.0526 4.2105 15.7105 
Std. Deviation 10.06409 11.34036 2.84460 2.58841 2.96062 6.62472 
Minimum 17.00 25.00 .00 1.00 .00 3.00 
Maximum 68.00 66.00 10.00 10.00 9.00 28.00 
 
 
4.4. Reliability 
Data analyses in this study began with the testing of the reliability of each of the three rating 
scales (Social Phobia Inventory – SPIN, Blushing Propensity Scale – BPS and Sheehan 
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Disability Scale – SDS). The rationale for reliability1 testing of each of these scales was to 
ensure that each of these instruments had provided accurate information from this sample. 
For this purpose, Cronbach’s Alpha was used to calculate the internal consistency of each 
item of a particular scale, in order to determine whether all items where relevant within a 
scale.  
  
The reliability analyses of the Blushing Propensity scale (BPS) are shown in figure 2 (see 
table below). These results indicate that the reliability of the Blushing Propensity scale is 
good, and that data gathered from this sample regarding blushing propensity is accurate.  
 
Figure 2 - Blushing Propensity Scale (BPS) 
Summary for scale: Mean=49.1316 Std.Dv.=11.3404 Vali      
Cronbach alpha: .913619 Standardized alpha: .914773
Average inter-item corr.: .443000
variable
Mean if
deleted
Var. if
deleted
StDv. if
deleted
Itm-Totl
Correl.
Alpha if
deleted
bps_1
bps_2
bps_3
bps_4
bps_5
bps_6
bps_7
bps_8
bps_9
bps_10
bps_11
bps_12
bps_13
bps_14
45.39474 108.7126 10.42653 0.611123 0.908109
46.00000 107.3158 10.35933 0.664894 0.906087
44.86842 110.2721 10.50105 0.670480 0.906451
46.28947 107.6267 10.37433 0.675659 0.905728
44.86842 107.8511 10.38514 0.695218 0.905123
44.86842 112.4827 10.60579 0.618065 0.908406
45.21053 112.1136 10.58837 0.448656 0.914288
46.05263 105.1025 10.25195 0.700747 0.904638
46.13158 105.5353 10.27304 0.701281 0.904625
45.05263 107.7341 10.37950 0.630299 0.907416
46.57895 106.7701 10.33296 0.680988 0.905462
46.34211 107.4882 10.36765 0.643726 0.906895
44.94737 112.2604 10.59530 0.534275 0.910686
46.10526 110.3573 10.50511 0.519427 0.911652
 
                                                          
1 Reliability assesses the consistency with which the instrument measures a construct (Foxcroft & Roodt, 2005) 
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Regarding the Sheehan Disability Scale (SDS), results of the reliability analysis are shown in 
figure 3 (see table below). These results also indicate that the reliability of the Sheehan 
Disability Scale is good, and that data gathered from this sample regarding disability is 
accurate.  
 
Figure 3 - Sheehan Disability Scale (SDS) 
Summary for scale: Mean=15.7105 Std.Dv.=6.62472 Vali      
Cronbach alpha: .694855 Standardized alpha: .693922
Average inter-item corr.: .434979
variable
Mean if
deleted
Var. if
deleted
StDv. if
deleted
Itm-Totl
Correl.
Alpha if
deleted
sh_w
sh_s
sh_f
11.26316 22.82548 4.777602 0.448448 0.680582
8.65789 24.17244 4.916547 0.479237 0.641971
11.50000 18.67105 4.321002 0.614981 0.457253
 
 
The Social Phobia Inventory (SPIN) was also analysed for reliability, although results were 
dissimilar to the first two rating scales. The results are summarised in figure 4 (see table 
below). The scale was found to be less reliable and less able to report accurately on symptom 
severity (social phobia/social anxiety disorder symptoms). In particular, item 17, which asks 
participants to rate the severity of their distress regarding trembling or shaking, was not found 
to be a reliable item of this rating scale and did not correlate highly with other items within 
this scale.  
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Figure 4 - Social Phobia Inventory (SPIN) 
Summary for scale: Mean=43.8947 Std.Dv.=10.0641 Valid     
Cronbach alpha: .819183 Standardized alpha: .820963
Average inter-item corr.: .220891
variable
Mean if
deleted
Var. if
deleted
StDv. if
deleted
Itm-Totl
Correl.
Alpha if
deleted
spin1
spin2
spin3
spin4
spin5
spin6
spin7
spin8
spin9
spin10
spin11
spin12
spin13
spin14
spin15
spin16
spin17
41.71053 88.36358 9.400190 0.427295 0.809198
41.65789 88.38297 9.401221 0.354900 0.814068
41.07895 84.49377 9.192049 0.609627 0.798070
41.60526 88.02840 9.382345 0.410908 0.810164
40.92105 88.59902 9.412705 0.457497 0.807747
40.65789 94.75139 9.734033 0.230120 0.818603
42.00000 84.21052 9.176629 0.471651 0.806456
41.44737 88.03671 9.382788 0.393427 0.811330
40.65789 91.75139 9.578694 0.301742 0.815999
41.86842 86.64058 9.308092 0.481612 0.805783
40.44737 91.77354 9.579851 0.319909 0.814997
41.26316 87.03602 9.329309 0.463301 0.806925
42.00000 84.63158 9.199542 0.562942 0.800454
41.05263 87.47092 9.352589 0.452290 0.807643
40.76316 87.97021 9.379244 0.511671 0.805057
41.81579 85.41343 9.241939 0.542623 0.801965
41.36842 94.33794 9.712772 0.093440 0.831979
 
 
4.5. Correlational Analyses 
4.5.1 Relationship between blushing propensity and disability 
The data from the Blushing Propensity Scale (BPS) and the Sheehan Disability Scale (SDS) 
were used in correlational analyses in order to investigate the relationship between blushing 
propensity and disability in social anxiety disorder. Four correlational analyses were done, 
namely; 1) between the total score of the BPS and the total score of the SDS (see figure 5), 2) 
between the total score of the BPS and the ‘’work subscale’’ of the SDS (see figure 6), 3) 
between the total score of the BPS and the ‘’social life subscale’’ of the SDS (see figure 7), 
and 4) between the total score of the BPS and the ‘’family life/home responsibilities 
subscale’’ of the SDS (see figure 8).  
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Figure 5 - BPS & SDS (Total) 
 
Figure 6 - BPS & SDS (Work) 
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Figure 7 - BPS & SDS (Social) 
 
 
Figure 8 - BPS & SDS (Family) 
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In summary, the Blushing Propensity Scale total is not significant correlated with the 
subscales of the Sheehan Disability Scale. However, there is a tendency towards a significant 
correlation between the Blushing Propensity Scale Total score and the Sheehan Disability 
Scale Total score (r=0.3, p=0.06). 
 
4.5.2 Relationship between severity of social anxiety disorder and disability 
The data from the Social Phobia Inventory (SPIN) and the Sheehan Disability Scale (SDS) 
were used in correlational analyses in order to investigate the relationship between severity 
and disability in social anxiety disorder. Four correlational analyses were done, namely; 1) 
between the total score of the SPIN and the total score of the SDS (see figure 9), 2) between 
the total score of the SPIN and the ‘’work subscale’’ of the SDS (see figure 10), 3) between 
the total score of the SPIN and the ‘’social life subscale’’ of the SDS (see figure 11), and 4) 
between the total score of the SPIN and the ‘’family life/home responsibilities subscale’’ of 
the SDS (see figure 12).  
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Figure 9 - SPIN & SDS (Total) 
 
 
Figure 10 - SPIN & SDS (Work) 
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Figure 11 - SPIN & SDS (Social) 
 
 
Figure 12 - SPIN & SDS (Family) 
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In summary, two positive and significant correlations were found. Firstly, between the 
severity of SAD (SPIN total) and the social subscale of the SDS (social disability) (r=0.43, 
p=0.01). Secondly, between the severity of SAD (SPIN total) and the SDS total (overall 
disability) (r=0.36, p=0.03).  
 
4.5.3 Relationship between blushing propensity and severity of social anxiety 
disorder 
The data from the Blushing Propensity Scale (BPS) and the Social Phobia Inventory (SPIN) 
were used in correlational analyses in order to investigate the relationship between blushing 
propensity and severity in social anxiety disorder (see figure 13).  
Figure 13 - BPS & SPIN 
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This indicates a significant positive correlation between blushing propensity and severity of 
SAD (r=0.59, p=<0.001).  
 
4.6. Conclusions of correlational analyses 
In summary, a significant positive correlation was found between blushing propensity and 
SAD severity. Two significant positive correlations were found between SAD severity and 
disability (both the total of the scale and the social subscale score). Lastly, a tendency 
towards a significant correlation was found between blushing propensity and disability (total 
score). As expected, this indicates existing relationships between blushing propensity, SAD 
severity and disability of SAD in this sample.  
 
4.7. Mediation Analyses 
Despite correlational analyses revealing relationships between all three variables investigated, 
as expected, no inferences can be made about the causality of these relationships. This 
information is useful in that it appears that these variable are interlinked, but the exact nature, 
direction and hierarchy these variables influence each other is unclear. The hypothesis at the 
beginning of this study was that a positive correlation would be found between blushing 
propensity and disability (i.e. the more blushing, the more disability). However, in the course 
of the correlational analyses, the severity variable appeared to also be involved to some 
degree in this relationship. As reported previously, severity is positively correlated with both 
blushing propensity and disability in SAD (both the total of the SDS scale and the social 
subscale of the SDS scale). In order to provide more clarity about the exact role blushing, 
severity and disability play in their relationship with SAD, the Sobel test of mediation was 
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performed. Thereby the degree of influence severity has in the blushing-disability 
relationship could be more clearly elucidated. 
 
In the Sobel analysis, blushing propensity (BPS) was the predictor, with disability (SDS total 
score) as the dependent variable and severity of SAD (SPIN) as the mediator (see figure 14). 
Severity was indeed found to be a mediating agent in the relationship between blushing 
propensity and disability in SAD (p=0.04).  
 
Figure 14 - Sobel Mediation Analysis 
Independent variable=bps_total mediator=spin_total Depen  
1
Indirect
effect
2
z-value
3
p-value
4
Bootstrap
95% CI
lower
5
Bootstrap
95% CI
upper
1 0.1319 2.0405 0.04 -0.0071 0.2834
 
 
The following chapter will discuss these results in more detail.  
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Chapter 5: Discussion 
 
5.1. Introduction 
This section consists of a discussion of the results in terms of the study hypotheses and 
existing literature.  
 
5.2. Clinical Variables 
The SAD severity score suggests moderately severe SAD in the study sample.  The study 
sample also reported a moderate propensity to blush.  SAD symptoms and blushing 
propensity appear to have been reported at similar levels of severity.  Regarding the SDS, 
there are four scores – the total score and three subscale totals. Each subscale assesses a 
different area of impairment – namely ‘’work’’, ‘’social life’’ and ‘’family life/home 
responsibilities’’. Compared to the mean scores for the ‘’work’’ and ‘’family life/home 
responsibilities’’ items (the levels of disability in these domains being similar), the ‘’social 
life’’ disability mean score was significantly higher. Disability in this domain of life can be 
expected as an excessive or irrational fear of scrutiny or rejection in social situations, with 
significant distress and/or avoidance of these social circumstances.  This is at the core of a 
SAD diagnosis (APA, 2000).    
 
Halberstadt and Green (1993) proposed that blushing may be linked specifically to the 
social setting, and may therefore also be fundamental to SAD. Blushing appears to be 
intrinsically a social device; a way for the body to manifest anxiety and fears about the 
presence of others (Halberstadt & Green, 1993, perhaps moreso in SAD.  The findings 
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suggest that blushing is also significantly associated with disability in terms of social 
functioning, and even more so with SAD severity. This provides strong support for the study 
hypotheses.   
 
5.3. Hypothesis 1: Individuals with SAD have the propensity to blush 
The first hypothesis of the current study was “Individuals with SAD have a propensity to 
blush’’-thus the study objective was to determine blushing propensity in the selected sample 
of SAD patients. 
 
All participants presented with clinically significant SAD. Participants in the study reported 
a ‘’moderate’’ propensity to blush. The first hypothesis explores how blushing fits with the 
social nature of SAD. A correlational analysis using results from the BPS and the SPIN was 
undertaken. The results indicated a significant positive correlation between propensity to 
blush and SAD symptom severity. This correlation thus suggests that blushing is increased 
when SAD severity is increased, and vice versa. Causality or direction of this relationship 
cannot however be inferred from the analyses.    
 
Evidence suggests that blushing is a somatic response to anxiety (Stein & Bouwer, 1997). 
At the core of SAD is anxiety, and specifically so in social situations. A link with blushing 
in these circumstances is thus expected. The significant positive correlation between totals 
on the SPIN and BPS thus makes good clinical sense – i.e. the more severe the SAD, the 
more the likelihood of blushing. Literature also showed that individuals with SAD that 
report a high blushing propensity experience the blushing as both embarrassing and anxiety-
provoking (Stein & Bower, 1997). Based on this theory, one can expect blushing to lead to 
further increases of SAD severity which may in turn spark further blushing – thus one may 
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argue that there is a cyclical relationship between blushing and illness severity in SAD. 
Furthermore, blushing is experienced as a negative occurrence, with some individuals 
describing it as descriptive of their shame and lack of worth (Crozier, 2007). Halberstadt 
and Green (1993) in their Social Attention Theory, described how blushing is proposed to 
be elicited by four factors, among them ‘’threats to public identity’’ and ‘’scrutiny’’. 
According to DSM-IV-TR (APA, 2000), SAD is defined as a disorder where the individual 
when exposed to possible scrutiny will show symptoms of anxiety (e.g. shaking, trembling, 
sweating) that they may find embarrassing. Blushing may also be noted.  It has also been 
shown that thoughts about these symptoms (e.g. that they are visible to other people, and 
that they will think less of him/her because of it) cause these individuals embarrassment, 
humiliation and distress – as accurately described by Crozier (2007). Halberstadt and Green 
(1993) also expressed that simply any form of attention from others may cause individuals 
with SAD to believe they are being threatened or scrutinised-thus causing symptoms (such 
as blushing) and distress. Individuals with SAD thus fear rejection or negative evaluation 
more than others (Stein & Bouwer, 1997; Leary & Meadows, 1991; Rapee & Heimbeig, 
1997). Halberstadt and Green (1993) also proposed that threats to public identity are a 
possible elicitor of blushing.  
 
In conclusion, the findings support the hypothesis of an important link between SAD and 
blushing that can be framed within the Social Attention Theory (Halberstadt & Green, 
1993).  This provides support for the hypothesis that individuals with SAD have an 
increased propensity to blush. Blushing therefore appears to be intricately linked to SAD, as 
blushing is intrinsically a social device; a way for the body to manifest anxiety and, 
specifically in SAD, fear about the presence of others (Halberstadt & Green, 1993). 
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Moreover, there is also evidence to suggest that as SAD symptoms increase, so does the 
propensity to blushing. However, no further inferences can be made from this data about 
causality however.  
 
5.4. Hypothesis 2: The propensity to blush is positively correlated with functional 
impairment associated with SAD 
The second objective of this study was to investigate the association between blushing 
propensity and the level of reported functional impairment in SAD patients. This relates to 
the second hypothesis of the current study, i.e. that the propensity to blush is positively 
correlated with the disability associated with SAD. The discussion of the aspect will proceed 
in two parts:  
 
5.4.1. SAD symptom Severity and Disability 
 
Firstly, in order to ascertain where disability is positioned, a correlational analysis was done 
on two variables – SAD symptom severity and disability (or, as above, functional 
impairment). A significant positive correlation was found between the SAD severity and 
disability in general.  
 
The second significant positive correlation found was between SAD severity and the 
‘’social’’ subscale of the SDS specifically. This is consistent with the fact that SAD is a 
disorder characterised primarily by a fear (and avoidance) of social situations (DSM-IV-TR, 
2000). This also provides some understanding as to why in SAD the more socially impaired 
the person is, the more disabled they will feel in general. The literature also suggests that 
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social impairment is most commonly and predictably seen in SAD (Lader, 1998). Negative 
perceptions of social situations and individuals’ performance in them are reinforced over 
time, leading to increased fear of social settings and subsequent avoidance behaviour (Safren, 
et al, 1997).  
 
This discussion asserts that for individuals with SAD that blushing is perceived as a 
negative occurrence, both shameful and incompetent, and would lead to rejection or 
negative evaluation in social situations. These cognitive distortions are explored. Voncken 
and Bögels (2008) reported on the core incongruence of individuals in terms of how they as 
opposed to others perceive them. According to that study, individuals with SAD tended to 
perform worse in social settings in comparison to individuals without SAD (Voncken and 
Bögels, 2008). It seems that these two factors are linked – the issue of a self-fulfilling 
prophecy may be relevant. I.e. when SAD is already present, the person is acutely aware of 
and fears social scrutiny and expects to be worse off than others. This increased self-
consciousness and lack of confidence may then lead to half-hearted attempts at being 
successful socially.  This in turn contributes to an objectively worse performance, which 
subsequently reinforces their anxiety and avoidance behaviours in the social context. The 
finding that individuals are mostly impaired in the social domain is dominant.  
 
5.4.2. Blushing Propensity and Disability 
Given that blushing propensity correlated with SAD severity, and that SAD severity was 
correlated with disability, it was hypothesised correctly that blushing propensity would also 
be significantly linked with disability in SAD. However, the findings suggested a tendency 
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towards a significant correlation between blushing propensity and general disability only. 
This seems to suggest that the relationship between the three variables in the current study is 
more complex and that there may be other variables influencing the relationship.  
 
Despite correlational analyses revealing relationships between all three variables 
investigated, no inferences can be made about the causality of these relationships. Indeed, 
the exact nature, direction and hierarchy of how these variables influence each other are 
unclear. Nevertheless, the findings are useful in showing that these concepts are interlinked 
in SAD.  The initial study hypothesis was that an association may be found between 
blushing propensity and disability (i.e. increased blushing associated with increased 
disability). However, following the correlational analysis, the SAD severity variable 
appeared to also be involved to some degree in this relationship. Indeed, it was found that 
SAD severity was positively correlated with both blushing propensity and disability in SAD.  
 
The mediation analysis was thus undertaken. Using the Sobel test, blushing propensity was 
inserted as the predictor variable, with disability as the dependent variable and severity as 
the mediator. The output confirmed a significant mediation role for SAD severity in terms 
of the association between blushing and disability in SAD.  This finding provides partial 
support for hypothesis 2, i.e. that disability does increase as blushing propensity increases, 
but that the association depends on the influence of SAD severity. Thus SAD severity can 
be seen as the mediator; for as social anxiety symptoms increase, so does the blushing 
propensity and the disability. It appears that the three are significantly interlinked and that 
each variable influences one another.  
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5.5 Conclusion 
In conclusion, this thesis shed some light on the associations between blushing, disability, 
and illness severity - in a sample of patients with a primary diagnosis of SAD.  SAD still 
lacks recognition and acknowledgement as a serious disorder with associated disability. 
Despite more recent awareness of SAD as a mental health condition, disability is 
underestimated. This stigma has lead to paucity in research around specific aspects of SAD 
e.g. blushing. SAD is associated with significant disability in all, and blushing in some cases. 
The relationship between these variables remains incompletely understood (Stein & Bouwer, 
1997; Leary et al, 1992; Leary & Meadows, 1991) and this research contributes to existing 
knowledge on the impact of blushing on disability in SAD. This contribution may enable 
clinicians to better diagnose and address in treatment various aspects of SAD such as 
blushing or disability that may be crucial. This research has shown how these elements are 
important in SAD.  Nevertheless, further research is required on the perceptions, beliefs and 
associated cognitive distortions individuals with SAD experience in relation to their blushing 
or their disability.  
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Chapter 6: Conclusion 
 
The current study focussed on SAD and two specific elements of SAD viz. blushing and 
disability. The study aimed to study the individual relationships between SAD and blushing, 
SAD and disability, and blushing and disability in this psychiatric disorder. 
 
The literature showed that blushing is common in SAD and an experience of anxiety for 
individuals with SAD (Stein & Bouwer, 1997). Individuals with SAD are reported to find 
blushing embarrassing, anxiety-provoking and a negative occurrence (Crozier, 2006), which 
may indicate a lack of worth and shame. Blushing has also been shown to be associated with 
negative evaluation in those easily embarrassed and socially anxious (Leary & Meadows, 
1991), which provides some evidence of a link between blushing and SAD. The known 
disability associated with SAD (Stein & Bower, 1997) may only increase when considering 
the addition of the negative perception and experience of blushing in individuals with SAD.  
 
A link between SAD and disability is clearly demonstrated in the literature (APA, 2000). 
Disability in SAD is reportedly experienced on numerous levels, including occupational, 
educational and social spheres (Lader, 1998). Cognitive biases are also reportedly involved in 
SAD (Voncken, Bögels & Peeters, 2007), with a focus on self-blaming, negative self-
perception, negative expectations of others’ evaluations and self-criticism. SAD is also 
associated with increased psychiatric comorbidity (Safren et al, 1997).  
 
As regards the relationship between blushing and SAD, and disability and SAD, the study 
findings provide some support for the hypothesis that there may be a significant relationship 
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between blushing propensity, SAD severity and disability in SAD. A significant positive 
correlation was found between blushing propensity and SAD severity. In addition, a tendency 
towards a significant correlation was found between blushing propensity and disability in 
general. SAD severity was also positively correlated with some aspects of disability.  
 
These results did not however provide any information on causality. A further analysis (Sobel 
test) was performed to investigate this issue. SAD severity was found to be a mediator in the 
relationship between blushing and disability in SAD. Therefore, no direct relationship was 
found between blushing and disability in SAD, although severity mediated the impact of 
blushing of disability.  
 
6.1. Limitations of the current study 
This study was limited in a number of areas; 
1. The sample size was relatively small and therefore little generalisation could be made 
from this sample. Unfortunately, given the population, a larger sample size may be 
difficult to obtain due to the very nature of the disorder (i.e. the study requires social 
interaction, the very thing individuals with SAD fear).  
2. The instruments used were self-report measures, which may not have provided the 
most reliable data. Participants may lie or report inaccurately and this may mean the 
data is not necessary as accurate.  
Nevertheless the study findings contribute to existing knowledge on SAD and should lead to 
further investigation in larger samples. 
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6.2. Recommendations 
Future work on the relationship between blushing and disability is recommended in order to 
further inform the treatment of this disorder. Work is currently being done at the University 
of Cape Town on the neural correlates of blushing. This study will provide information on the 
elicitors of blushing during imaging, in order to better inform treatment protocols of blushing. 
More similar work is required in the field, as blushing in an important area of focus, 
particularly in the social realm and that of SAD. Future work would enable better 
conceptualisation and treatment of the disorder, and hopefully reduce the stigmatisation of 
those who experience SAD.   
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MRC UNIT ON ANXIETY AND STRESS DISORDERS 
 
PATIENT INFORMATION AND INFORMED CONSENT 
Genetics of Anxiety Disorders 
 
PURPOSE: 
 
This study is part of a research project we are conducting to learn more about the genetic causes and 
symptoms of anxiety disorders (including obsessive-compulsive and spectrum disorders such as 
trichotillomania (TTM), panic or social anxiety disorder).  We would like to discuss your life experiences 
and those of your other family members with you.  Doctors and scientists at the MRC Unit on Anxiety and 
Stress Disorders and the University of Stellenbosch, in collaboration with qualified researchers from other 
research institutions worldwide, hope to identify the genes that may increase susceptibility to these 
disorders. 
This is not a treatment study.  Information is being collected for research purposes only. 
 
STUDY PROCEDURE: 
 
If you decide to participate, we shall ask you to attend an interview (which may be videotaped) with a 
researcher.  This interview will include neuropsychological tasks and a number of questions related to 
your current illness, comorbid conditions like depression, family functioning, quality of life, your prior 
history of treatment for psychiatric conditions, and particular symptoms you may have experienced as part 
of your illness.  In addition, we may ask to take photographs of your face and hands.  This whole 
procedure will last about 4-5 hours (two 2-hour sessions with a break in-between).   
 
You will also be asked to have your blood drawn.  Approximately 48 ml (3 tablespoons) of blood will be 
drawn from your arm.  We may need to contact you again to get another blood sample should we fail to 
get a DNA sample from your blood.  The blood sample you give may be used to create a cell line.  This is 
done by changing some of your blood cells so that they can grow forever.  The cell line is living tissue and 
it can be used to make more of your DNA at any time in the future.  This process will take place at the 
MRC Centre for Molecular and Cellular Biology and the Division of Medical Biochemistry, Faculty of 
Health Sciences, at the University of Stellenbosch.  The DNA will then be taken from the cell line and 
saved for scientific analyses which will be performed now, and possibly in the future.   
 
We may contact you later for further information, or request you to complete another interview at a later 
date, in order to obtain follow-up information that may be of use in our genetic analyses.  This may 
involve an assessment similar to the current assessment, including a series of interviews and/or another 
blood sample.  Your current participation is in no way binding to your future participation. 
 
We would like your permission to contact your relatives in order to get more information about any family 
history of mental illness, if need be.   
 
If you have been diagnosed with TTM, we hope to also interview one of your close (first-degree) relatives.  
You can still participate in the study even if your relatives do not.  If you are a relative (e.g. a parent) of a 
person diagnosed with TTM who have participated in this project, we will ask you to complete a number 
of self-report scales.  These scales will ask questions about your current psychiatric symptoms if any, 
depression, anxiety, family functioning and quality of life.  These scales will also ask you whether your 
child has tics, OCD and other problems.  They will also ask about your child’s psychiatric condition and 
how you respond to it.  It can take up to 4 hours to complete these self-report scales – either at home or 
at our Unit. 
 
Personal information that could be used to identify you (such as your name, contact information, etc.) will 
not be given out.  Your data and DNA is likely to be made available to qualified scientists around the 
world to study your particular disorder.  Your cell line and DNA will be maintained permanently, unless 
you request to have it removed.  If at any time in the future you wish to have your DNA, cell lines or 
clinical data removed from the storage site, you may do so by contacting the researchers conducting this 
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study (Christine Lochner at 021 - 938 9179). 
 
The researchers who will have access to your DNA include those who work with private and/or for profit 
companies.  These researchers may be interested in eventually developing commercial medical products 
using the DNA from you and other participants.  They may sell or patent discoveries based on this 
research and thus benefit financially.  Please note that you or your heirs will not receive any 
compensation if this occurs.    
 
We do not expect to discover any information of direct benefit to your condition, or your treatment, during 
the next few years.  If later on, diagnostic tests or new ways to treat your condition are discovered, this 
information will have to be obtained from properly licensed clinical labs, clinics, or your physician, and will 
not be available from the research team. 
 
If you are hospitalized at a psychiatry facility or have received any treatment from a mental health 
professional, we would like your permission to review your treatment records, which will be obtained from 
your doctor. 
 
RISKS:     
 
There are no more than minimal medical or psychological risks associated with this study.  If you feel 
fatigued, tired, uncomfortable, or in any way upset during any part of the session(s), you may ask to stop 
for a rest break or have the interview discontinued.  The research interview does not take the place of a 
full psychiatric evaluation.  You may experience some emotional discomfort when answering some 
questions.  If any particular question makes you feel uncomfortable, you may discuss its importance with 
the specially trained interviewer.  You may choose not to answer any question which you are still 
uncomfortable with. 
 
You may feel some pain associated with having blood withdrawn from a vein.  You may experience 
discomfort, bruising and/or other bleeding at the site where the needle is inserted.  Occasionally, some 
people experience fleeting dizziness or feel faint when their blood is drawn. 
 
Some insurance companies may mistakenly assume that your participation in this study is an indication 
that you are at higher risk of a genetic disease, and this could hurt your access to health or other 
insurance.  We will not share any information about you, or your family, with an insurance company.  
However, if you discuss your participation in this study with your doctor, and he or she records it in your 
medical record, it is possible that an insurance company may access the information as part of a medical 
record review.  It is the opinion of the investigators that participation in this study does not constitute 
genetic testing.  Although one long-term goal of this research is the development of a genetic test for the 
anxiety disorders, at the current time, no information from your DNA sample that would be useful in the 
treatment of your disorder will be obtained.  Therefore, participation in this study should not be reported 
as genetic testing.   
 
Your unidentified DNA and cell line will be available to qualified researchers permanently.  
 
BENEFITS:   
 
There are no direct benefits to you.  However, individuals who might develop one or more of these 
anxiety disorders in the future, their family members, and future generations may benefit if we can locate 
the genes that lead to such disorders.  That knowledge could then lead to the development of methods 
for prevention and new treatments for curing these diseases.   
 
CONFIDENTIALITY:    
 
If you consent to participate in this study, your identity will be kept confidential.  Your answers will not be 
shared with other family members or anyone else except for staff members involved in this study.  All data 
will be kept in locked file cabinets accessible only to the research staff.  All research information obtained 
will not be associated with your name; research staff will use only a coded number and/or your initials.  
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Blood samples will be safely stored and identified by code number and access will be limited to 
authorized scientific investigators.  Copies of treatment records from hospitals or mental health 
professionals are kept in locked files and are reviewed by members of the research team only.  Any 
publications resulting from this study will not identify you by name.   
 
VOLUNTARY PARTICIPATION: 
 
Your participation in this study is voluntary and you may refuse to participate or withdraw from the study 
at any time without any loss of benefits to which you are otherwise entitled.  Some members of the team 
of investigators conducting this study may be responsible for your clinical care.  Refusal to participate in 
this study will not change your clinical care. 
 
RESEARCH QUESTIONS AND CONTACTS: 
 
If you are interested in genetic counseling, you will be given information about where you can receive 
such counseling and a new blood sample may be required at that time.  DNA information about a relative 
will be released only if the genetic counsellor confirms that the relative in question is deceased or cannot 
be found and that the information is essential for clinical counseling. 
 
The researchers will answer any questions you might have about the procedures described above, or 
about the results of the study.  If you have any questions, you may call Dr Christine Lochner at (021) 938 
9179.   
 
The University of Stellenbosch Committee for Human Research has approved recruitment and 
participation of individuals for this study. 
 
You have been given a copy of this consent form to keep.   
 
INFORMED CONSENT/ASSENT TO TAKE PART AND AUTHORIZATION TO USE OR SHARE 
HEALTH INFORMATION FOR RESEARCH: 
 
I have read the above patient information, the research study has been explained to me, including risks 
and benefits (if any), all my questions have been answered, and I consent voluntarily to participate in this 
study. 
 
Print name:  _____________________________      Signature:  ____________________________ 
 (Adults or Minors younger than 18 years) 
 
Date: ________________________________ 
 
OR 
 
I understand the information that was given to me, and would like to give permission for my child/the 
person I am authorized to represent, to take part in this research study, and also agree to allow his/her 
health information to be used and shared as described above.  
 
Print name:  _____________________________      Signature:  ____________________________ 
 (Parent / Guardian of Minor) 
 
Date: ________________________________ 
 
OR 
 
Print name:  _____________________________      Signature:  ____________________________ 
 (Family member / next of kin) 
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Date: ________________________________ 
Relationship to patient: __________________________________ 
 
I have discussed the proposed research with this subject and, in my opinion, this patient understands the 
benefits, risks, and alternatives (including non-participation) and is capable of consenting to voluntary 
participation. 
 
 
Print name:  ______________________________      Signature:  ____________________________ 
 (Study Investigator or Designee) 
 
Date: ________________________________ 
 
 
Print name:  _______________________________     Signature:  ____________________________ 
 (Witness (if applicable)) 
 
Date: ________________________________ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lochner et al, Approved Version 5, July 2007 
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MNR EENHEID VIR ANGS- EN STRESSTEURINGS 
 
PASIëNTINLIGTING EN INGELIGTE TOESTEMMING 
Genetika van Angssteurings 
 
 
DOELWIT: 
 
Hierdie projek is deel van 'n navorsingsprojek wat tans onderneem word om meer uit te vind oor die 
genetiese oorsake en simptome van angssteurings (insluitend obsessief-kompulsiewe- en 
spektrumversteurings soos trichotillomanie (TTM), paniek-, of sosiale angssteuring).  Ons wil graag oor u 
lewenservarings en dié van u gesinslede met u gesels.  Dokters en wetenskaplikes by die MNR Eenheid 
vir Angs- en Stressteurings en die Universiteit van Stellenbosch, in samewerking met gekwalifiseerde 
navorsers van ander navorsingsinstellings wêreldwyd, hoop om die gene wat vatbaarheid vir hierdie 
angssteurings laat toeneem, te identifiseer. 
Dit is nie 'n behandelingstudie nie.  Inligting word alleenlik vir navorsingsdoeleindes versamel. 
 
PROJEKPROSEDURE: 
 
Indien u besluit om deel te neem, sal ons u vra om 'n onderhoud (wat moontlik op videoband vasgelê kan 
word,) met 'n navorser te voer.  Hierdie onderhoud sluit neurosielkundige take en 'n aantal vrae in wat 
met die volgende aspekte verband kan hou: u huidige siekte, komorbiede toestande soos depressie, 
gesinsfunksionering, lewenskwaliteit, u geskiedenis van behandeling vir psigiatriese steurings, en 
spesifieke simptome wat u dalk kon ervaar as deel van u siekte.  Daarmee saam, kan ons u vra om foto's 
van u hande en gesig te neem.  Hierdie hele prosedure sal ongeveer 4-5 ure duur (twee 2-uur sessies 
met 'n pouse tussen-in). 
 
U sal ook gevra word om toe te laat dat u bloed getrek word.  Ons kan dalk weer met u in verbinding 
moet tree om nog 'n bloedmonster te trek in geval ons nie daarin kon slaag om 'n DNA monster van u 
bloed te verkry nie.  Die bloedmonster wat u gee, kan gebruik word om 'n sellyn te skep.  Dit word gedoen 
deur sommige van u bloedselle te verander sodat dit vir altyd kan groei.  Die sellyn is lewende weefsel en 
dit kan gebruik word om meer van u DNA in die toekoms te maak.  Hierdie proses sal plaasvind by die 
MNR Sentrum vir Molekulêre en Sellulêre Biologie en die Afdeling Geneeskundige Biochemie, Fakulteit 
Gesondheidswetenskappe, Universiteit van Stellenbosch.  Die DNA sal dan van die sellyn geneem en 
gehou word vir wetenskaplike analise wat nou, en moontlik in die toekoms gedoen sal word.  
 
Ons kan met u in aanraking kom vir verdere inligting, of u vra om nog 'n onderhoud te voltooi op 'n latere 
stadium, ten einde opvolg-inligting te bekom wat gebruik kan word in ons genetika-analise.  Dit kan 'n 
soortgelyke assessering as die huidige wees, insluitend 'n reeks van onderhoude en/of ander 
bloedmonsters behels.  U huidige deelname verbind u onder geen omstandighede tot toekomstige 
deelname nie. 
 
Ons wil graag u toestemming hê om met u familielede in aanraking te kom ten einde meer inligting oor 
enige familiegeskiedenis van geestessiekte te bekom, indien nodig. 
 
Indien u met TTM gediagnoseer is, hoop ons om ’n onderhoud met een van u nabye familielede te voer.  
U kan steeds deelneem aan die projek selfs al is u familielede nie betrokke nie.  Indien u ’n familielid (bv. 
’n ouer) is van ’n persoon met TTM wat aan die projek deelgeneem het, sal ons u vra om ’n aantal 
selfrapporteringsvraelyste te voltooi.  Hierdie vraelyste sal vrae vra oor u huidige psigiatriese simptome 
(indien enige), depressie, angs, gesinsfunksionering en lewenskwaliteit.  Hierdie vraelyste sal ook vra oor 
u familielid met TTM se psigiatriese toestand en hoe u daarop reageer.  Dit kan tot 4 ure duur om hierdie 
selfrapporteringsvarelyste te voltooi – òf tuis òf hier by ons Eenheid. 
 
Persoonlike inligting wat gebruik kan word om u te identifiseer (soos u naam, kontakbesonderhede, ens.), 
sal nie uitgegee word nie.  U data en DNA sal moontlik aan gekwalifiseerde wetenskaplikes regoor die 
wêreld beskikbaar gestel word om u betrokke angssteuring te bestudeer.  U sellyn en DNA sal permanent 
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gehou word, behalwe wanneer u vereis dat dit verwyder word.  Indien u op enige stadium in die toekoms 
besluit om u DNA, sellyne of kliniese inligting uit die bergingsplek te laat verwyder, kan u dit doen deur 
die navorsers wat hierdie projek behartig, te vra om dit te doen (Christine Lochner by 021 - 938 9179). 
 
Die navorsers wat tot u DNA toegang het, sluit diegene in wat werk met private en/of winsgeoriënteerde 
maatskappye.  Hierdie navorsers kan ook daarin geïnteresseerd wees om uiteindelik kommersiële 
mediese produkte te ontwikkel deur van u en die ander deelnemers se DNA gebruik te maak.  Hulle kan 
hierdie uitvindings, wat op hierdie navorsing gebaseer is, verkoop of patenteer en sodoende finansieel 
daaruit voordeel trek.  Let asseblief daarop dat u of u erfgename nie enige kompensasie hiervoor sal 
ontvang indien dit wel gebeur nie. 
 
Ons verwag nie om enige inligting te bekom wat van direkte nut vir u toestand of u behandeling 
gedurende die volgende paar jare sal wees nie.  Indien daar in die toekoms diagnostiese toetse of nuwe 
wyses om u toestand te behandel, ontdek word, sal hierdie inligting van behoorlik gelisensieërde kliniese 
laboratoria, klinieke, of u mediese dokter verkry moet word, en dus nie van die navorsingspan nie. 
 
Indien u by 'n psigiatrie fasiliteit gehospitaliseer word, of behandeling van 'n geestesgesondheidswerker 
ontvang, wil ons graag u toestemming hê om u behandelingsrekords, wat van u dokter verkry sal word, 
na te gaan. 
 
RISIKO'S: 
 
Daar is nie meer as die minimum mediese en sielkudige risiko's geassosieer met hierdie projek nie.  
Indien u uitgeput, ongemaklik, of ontsteld raak tydens enige gedeelte van die sessie(-s), kan u vra om te 
onderbreek vir 'n ruskansie of om die onderhoud te beëindig.  Die onderhoud wat met u gevoer word, 
neem nie die plek van 'n deeglike psigiatriese evaluasie nie.  U kan dalk 'n mate van emosionele 
ongemak verduur wanneer u sommige van die vrae beantwoord.  Indien enige vraag u ongemaklik laat 
voel, kan u die belang daarvan met die spesiaal opgeleide onderhoudvoerder bespreek.  U kan verkies 
om enige vraag waarmee u steeds ongemaklik voel, nie te beantwoord nie. 
 
U kan moontlik 'n mate van pyn ervaar wanneer die bloed getrek word.  U kan ongemak, kneusing en/of 
bloeding by die plek waar die naald ingesteek word, ervaar.  Soms ervaar sommige persone 
verbygaande duiseligheid of 'n flou gevoel wanneer hulle bloed getrek word. 
 
Sommige versekeringsmaatskappye kan verkeerdelik aanneem dat u deelname aan hierdie projek 'n 
aanduiding is dat u 'n verhoogde risiko het vir 'n genetiese siekte, en dit kan u toegang tot gesondheid- of 
ander versekering skaad.  Ons sal nie enige inligting oor u, of u familie aan 'n versekeringsmaatskappy 
bekendmaak nie.  Indien u egter u deelname met u dokter bepreek, en hy/sy maak 'n nota daarvan in u 
mediese rekord, is dit moontlik dat 'n versekeringsmaatskappy hierdie inligting as deel van 'n hersiening 
van mediese rekords kan bekom.  Dit is die mening van die navorsers dat deelname aan hierdie studie 
nie genetiese toetsing is nie.  Alhoewel een langtermyn-doelwit van hierdie navorsing die ontwikkeling 
van 'n genetiese toets vir die angssteurings is, sal geen inligting van u DNA-monster wat nuttig kan wees 
in die behandeling van u toestand, tans verkry word nie.  Daarom behoort deelname aan hierdie studie 
nie as genetiese toetsing beskryf te word nie. 
 
U ongeïdentifiseerde DNA en sellyn sal permanent aan gekwalifiseerde navorsers beskikbaar wees.    
 
VOORDELE: 
 
Daar is geen direkte voordele vir u nie.  Individue wat egter in die toekoms een of meer van hierdie 
angssteurings ontwikkel, hulle familielede, en toekomstige generasies, kan voordeel daaruit put as ons 
die gene wat tot sulke versteurings aanleiding kan gee, kan identifiseer.  Hierdie kennis kan dan lei tot die 
ontwikkeling van metodes vir voorkoming en nuwe behandelingswyses vir genesing van die siektes. 
 
VERTROULIKHEID: 
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Indien u toestem tot deelname aan die projek, sal u identiteit vertroulik gehou word.  U antwoorde sal nie 
met u familielede of enige iemand anders behalwe die personeellede wat gemoeid is met hierdie projek, 
gedeel word nie.  Alle inligting sal in geslote liasseringskabinette wat slegs vir navorsingspersoneel 
toeganklik is, gehou word.  Alle navorsingsinligting wat verkry word, sal nie met u naam verbind kan word 
nie; navorsingspersoneel sal bloot 'n kodenommer en/of u voorletters gebruik.  Bloedmonsters sal veilig 
gestoor en geïdentifiseer word deur die kodenommer, en toegang sal tot die gemagtigde wetenskaplike 
navorsers beperk wees.  Kopieë van behandelingsrekords van hospitale of geestesgesondheidswerkers 
word in geslote lêers gehou en word slegs deur lede van die navorsingspan deurgegaan.  Enige 
publikasie wat uit hierdie projek voorspruit, sal u nie by name identifiseer nie. 
 
VRYWILLIGE DEELNAME: 
 
U deelname aan hierdie projek is vrywillig en u kan deelname weier of u op enige stadium van die projek 
onttrek sonder verlies van enige voordele waartoe u andersins geregtig is.  Sommige lede van die span 
navorsers wat hierdie projek uitvoer, kan moontlik verantwoordelik wees vir u kliniese versorging.  
Weiering om deel te neem aan hierdie studie sal nie u kliniese versorging verander nie. 
 
VRAE OOR DIE NAVORSING EN KONTAKBESONDERHEDE: 
 
Indien u wel in genetiese berading geïnteresseerd is, sal u inligting oor waar sodanige berading 
beskikbaar is, ontvang en 'n nuwe bloedmonster kan op daardie stadium vereis word.  DNA-inligting van 
'n familielid sal slegs beskikbaar gestel word indien die genetiese berader bevestig dat die familielid 
oorlede is of nie opgespoor kan word nie en dat die inligting noodsaaklik is vir kliniese berading. 
 
Die navorsers sal enige vrae wat u mag hê oor bogenoemde prosedures of oor die resultate van die 
projek, beantwoord.  Indien u enige navrae het, kan u Dr. Christine Lochner by 021 - 938 9179 skakel. 
 
Die Komitee vir Mensnavorsing van die Universiteit van Stellenbosch het die werwing en deelname van 
individue aan hierdie projek goedgekeur. 
 
U het 'n afskrif van hierdie toestemmingsvorm ontvang om te bewaar. 
 
INGELIGTE TOESTEMMING TOT DEELNAME EN TOESTEMMING OM GESONDHEIDSINLIGTING 
VIR NAVORSING TE GEBRUIK EN TE DEEL: 
 
Ek het die bostaande pasiëntinligting gelees, die navorsingstudie is aan my verduidelik, insluitend die 
risiko’s en voordele (indien enige), al my vrae is beantwoord, en ek stem vrywillig in om aan hierdie projek 
deel te neem. 
 
 
Naam: _____________________________  Handtekening: _____________________________ 
 (Volwassenes of Minderjariges jonger as 18 jaar) 
 
Datum: _____________________________ 
 
OF 
 
Ek verstaan die inligting wat aan my gegee is, en gee toestemming aan my kind/die persoon wat ek wetlik 
verteenwoordig, om deel te neem aan hierdie navorsingstudie, en stem toe dat sy/haar 
gesondheidsinligting gebruik en gedeel kan word soos hierbo beskryf. 
 
Naam: _____________________________  Handtekening: _____________________________ 
 (Ouer / Voog van Minderjarige) 
 
Datum: _____________________________ 
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OF 
 
Naam: _____________________________  Handtekening: _____________________________ 
 (Familielid / naasbestaande) 
 
Datum: _____________________________ 
Verwantskap aan pasiënt: ________________________________ 
 
Ek het die voorgestelde projek met die deelnemer bespreek en, na my mening, verstaan die deelnemer 
die voordele, risiko's, en alternatiewe (inlsuitend nie-deelname) en is in staat om toestemming te gee vir 
vrywillige deelname. 
 
Naam: ______________________________      Handtekening: ___________________________ 
 Navorser of Gemagtigde 
 
Datum: ______________________________ 
 
 
Naam: ______________________________      Handtekening: ___________________________ 
 Getuie (indien van toepassing) 
 
Datum: ______________________________ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lochner et al, Approved Version 5, July 2007 
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Social Phobia Inventory (SPIN) 
 
Please check how much the following problems have bothered you during 
the past week. Mark only one box for each item and be sure to answer all 
items. 
 
ITEM DESCRIPTION 
   N
ot at all 
A little bit 
Som
e w
hat 
Very m
uch 
Extrem
ely 
1. I am afraid of people in authority. 0 1 2 3 4 
2. I am bothered by blushing in front of people. 0 1 2 3 4 
3. Parties and social events scare me. 0 1 2 3 4 
4. I avoid talking to people I don’t know. 0 1 2 3 4 
5. Being criticized scares me a lot. 0 1 2 3 4 
6. Fear of embarrassment causes me to avoid doing 
things or speaking to people. 
0 1 2 3 4 
7. Sweating in front of people causes me distress. 0 1 2 3 4 
8. I avoid going to parties. 0 1 2 3 4 
9. I avoid activities where I am the centre of 
attention. 
0 1 2 3 4 
10. Talking to strangers scares me. 0 1 2 3 4 
11. I avoid having to give speeches. 0 1 2 3 4 
12. I would do anything to avoid being criticized. 0 1 2 3 4 
13. Heart palpitations bother me when I am around 
people. 
0 1 2 3 4 
14. I am afraid of doing things when people might be 
watching. 
0 1 2 3 4 
15. Being embarrassed or looking stupid are my 
worst fears. 
0 1 2 3 4 
16. I avoid speaking to anyone in authority. 0 1 2 3 4 
17. Trembling or shaking in front of others is 
distressing to me. 
0 1 2 3 4 
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Blushing Propensity Scale 
 
(Leary & Meadows, 1991) 
 
 
Indicate how often you feel yourself blush in each of the following situations using the scale 
below: 
 
 
 1 = I NEVER feel myself blush in this situation. 
 2 = I RARELY feel myself blush in this situation. 
 3 = I OCCASIONALLY feel myself blush in this situation. 
 4 = I OFTEN feel myself blush in this situation. 
 5 = I ALWAYS feel myself blush in this situation. 
 
 
 ____  1.  When a teacher calls on me in class 
 
 ____  2.  When talking to someone about a personal topic 
 
 ____  3.  When I'm embarrassed 
 
 ____  4.  When I'm introduced to someone I don't know 
 
 ____  5.  When I've been caught doing something improper or shameful 
 
 ____  6.  When I'm the center of attention 
 
 ____  7.  When a group of people sings "Happy Birthday" to me 
 
 ____  8.  When I'm around someone I want to impress 
 
 ____  9.  When talking to a teacher or boss 
 
 ____ 10.  When speaking in front of a group of people 
 
 ____ 11.  When someone looks me right in the eye 
 
 ____ 12.  When someone pays me a compliment 
 
 ____ 13.  When I've looked stupid or incompetent in front of others 
 
 ____ 14.  When I'm talking to a member of the other sex 
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Sheehan Disability Scale (SDS) 
 
 
Please circle the number that best describes the way you have felt over the past week. 
 
 
 
                                                             Work 
 
                                These symptoms have disrupted your work 
 
 
 
Not at all     Mildly   Moderately       Markedly     Extremely 
            
______________________________________________________________ 
0     1     2    3 4 5 6 7 8 9 10 
 
 
 
 
                                                   Social Life 
 
                           These symptoms have disrupted your social life 
 
 
Not at all     Mildly   Moderately       Markedly     Extremely 
            
______________________________________________________________ 
0     1     2    3 4 5 6 7 8 9 10 
 
 
 
 
 
                                         Family life/Home responsibilities 
 
               
 
Not at all     Mildly   Moderately       Markedly     Extremely 
            
______________________________________________________________ 
0     1     2    3 4 5 6 7 8 9 10 
 
 
 
 
 
 
